NasdaqGS - Delayed Quote USD
Metagenomi, Inc. (MGX)
1.6000
+0.0500
+(3.23%)
At close: May 13 at 4:00:02 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 90,425 | 5 |
| Sales | 4,297 | 3 |
| Net Shares Purchased (Sold) | 86,128 | 8 |
| Total Insider Shares Held | 10.57M | -- |
| % Net Shares Purchased (Sold) | 0.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| NOONBERG SARAH B Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2025 |
| WAPNICK PAMELA M. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2025 |
| THOMAS BRIAN C Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2025 |
| WEIN MATTHEW Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2025 |
| IRISH JIAN PH.D. President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2025 |
| WAPNICK PAMELA M. Chief Financial Officer | Sale at price 1.87 per share. | Direct | 3,390 | Mar 5, 2025 |
| WEIN MATTHEW Officer | Sale at price 1.87 per share. | Direct | 1,744 | Mar 5, 2025 |
| WAPNICK PAMELA M. Chief Financial Officer | Sale at price 1.86 per share. | Direct | 2,900 | Dec 5, 2024 |
| WAPNICK PAMELA M. Chief Financial Officer | Sale at price 2.88 per share. | Direct | 18,043 | Sep 5, 2024 |
| BORGES LUIS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2024 |
| NOONBERG SARAH B Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2024 |
| HARNEST SIMON Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2024 |
| WAPNICK PAMELA M. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2024 |
| DELANEY SIMREN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2024 |
| THOMAS BRIAN C Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2024 |
| WEIN MATTHEW Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2024 |
| IRISH JIAN PH.D. President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 1, 2024 |
| NOVO HOLDINGS A/S Beneficial Owner of more than 10% of a Class of Security | Purchase at price 10.25 - 11.69 per share. | Direct | 10,377,000 | Feb 13, 2024 |
| NOVO HOLDINGS A/S Beneficial Owner of more than 10% of a Class of Security | -- | Direct | -- | Feb 13, 2024 |
| BAYER HEALTHCARE L.L.C. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Feb 13, 2024 |
| BERNALES SEBASTIAN PH.D. Director | -- | Indirect | -- | Feb 13, 2024 |
Related Tickers
GPCR Structure Therapeutics Inc.
23.89
-2.97%
PRME Prime Medicine, Inc.
1.2700
-5.22%
ACET Adicet Bio, Inc.
0.6680
-7.35%
ACRV Acrivon Therapeutics, Inc.
1.1300
-5.83%
IPSC Century Therapeutics, Inc.
0.5260
+0.25%
KYTX Kyverna Therapeutics, Inc.
2.3200
+4.98%
CRBU Caribou Biosciences, Inc.
0.7828
-4.31%
SANA Sana Biotechnology, Inc.
1.7950
-10.25%
KROS Keros Therapeutics, Inc.
13.47
-1.97%
VERV Verve Therapeutics, Inc.
4.1600
-4.37%